KD Logo

MaxCyte Inc (MXCT) gets rating Initiated from Craig Hallum

MaxCyte Inc’s filing revealed that its Director Johnston John Joseph unloaded Company’s shares for reported $22025.0 on Mar 26 ’24. In the deal valued at $4.41 per share,5,000 shares were sold. As a result of this transaction, Johnston John Joseph now holds 120,583 shares worth roughly $0.44 million.

Then, Johnston John Joseph sold 5,000 shares, generating $25,585 in total proceeds. Upon selling the shares at $5.12, the Director now owns 120,583 shares.

Before that, Johnston John Joseph sold 5,000 shares. MaxCyte Inc shares valued at $22,650 were divested by the Director at a price of $4.53 per share. As a result of the transaction, Johnston John Joseph now holds 120,583 shares, worth roughly $0.44 million.

Craig Hallum initiated its MaxCyte Inc [MXCT] rating to a Buy in a research note published on November 29, 2023; the price target was $7. William Blair began covering MXCT with “an Outperform” recommendation on August 24, 2021. Wedbush started covering the stock on August 24, 2021. It rated MXCT as “an Outperform”.

Price Performance Review of MXCT

On Tuesday, MaxCyte Inc [NASDAQ:MXCT] saw its stock fall -0.82% to $3.63. Over the last five days, the stock has lost -4.47%. MaxCyte Inc shares have fallen nearly -22.77% since the year began. Nevertheless, the stocks have fallen -27.40% over the past one year. While a 52-week high of $5.55 was reached on 01/12/24, a 52-week low of $2.45 was recorded on 04/30/24. SMA at 50 days reached $4.18, while 200 days put it at $4.15. A total of 0.52 million shares were traded, compared to the trading of 0.34 million shares in the previous session.

Levels Of Support And Resistance For MXCT Stock

The 24-hour chart illustrates a support level at 3.56, which if violated will result in even more drops to 3.50. On the upside, there is a resistance level at 3.70. A further resistance level may holdings at 3.78. The Relative Strength Index (RSI) on the 14-day chart is 29.96, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.66%. Stochastics %K at 14.20% indicates the stock is a buying.

The most recent change occurred on August 24, 2021 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $18 price target.

Most Popular

[the_ad id="945"]